Increased Plasma Concentration of Brain-Derived Neurotrophic Factor With Electroconvulsive Therapy: A Pilot Study in Patients With Major Depression
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The therapeutic mechanism of electroconvulsive therapy (ECT) is unknown. Animal research supports a neurotrophic effect of ECT. To investigate a neurotrophic effect in humans, we examined whether plasma concentration of brain-derived neurotrophic factor (BDNF) increases in patients receiving ECT for major depression. METHOD: We conducted a prospective, self-controlled study of 15 patients with a DSM-IV diagnosis of major depressive episode who were referred for ECT at the University of Maryland Medical Center (Baltimore, Md.) between January 2004 and September 2005. Plasma BDNF concentration was measured by enzyme-linked immunosorbent assay before and during an acute course of ECT. Depression severity was measured using the 21-item Hamilton Rating Scale for Depression (HAM-D). RESULTS: ECT resulted in a significant increase in plasma BDNF (Z = 2.897, p = .004) from a pre-ECT median of 84.9 pg/mL to a post-ECT median of 141.2 pg/mL. This change was accompanied by a significant decrease in HAM-D score (Z = 3.411, p = .001) from a pre-ECT median of 30.0 to a post-ECT median of 9.0. BDNF increased in 13 (86.7%) of 15 subjects. CONCLUSION: This is the first report of an increase in plasma BDNF concentration in patients receiving ECT. These preliminary results encourage further investigation of a neurotrophic mechanism for the antidepressant effect of ECT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Kennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Fernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389
Hashimoto, K. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02113.x · Cited by 388
Determinants of serum brain-derived neurotrophic factor.
Bus, B. A. A., Molendijk, M. L., Penninx, B. J. W. H., Buitelaar, J. K., Kenis, G., Prickaerts, J., Elzinga, B. M., & Voshaar, R. C. O. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.013 · Cited by 279
Nordanskog, P., Dahlstrand, U., Larsson, M. R., Larsson, E.-M., Knutsson, L., & Johanson, A. (2010) · The Journal of ECT · doi:10.1097/yct.0b013e3181a95da8 · Cited by 219
“In humans, BDNF protein immunoreactivity was elevated in postmortem tissue from patients treated with antidepressive drugs, and increased plasma concentration of BDNF has recently been shown in patients receiving ECT.(44) Another mechanism of action of ECT, indicating morphological properties, is by its normalization…”
BackgroundInfluentialKozisek, M. E., Middlemas, D., & Bylund, D. B. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.07.001 · Cited by 205
How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms
Singh, A., & Kar, S. K. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.3.210 · Cited by 195
Depression in Alzheimer's Disease: Epidemiology, Mechanisms, and Management
Chi, S., Yu, J.-T., Tan, M.-S., & Tan, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140324 · Cited by 165
Machado-Vieira, R., Yuan, P., Brutsche, N., DiazGranados, N., Luckenbaugh, D., Manji, H. K., & Zarate, C. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04659 · Cited by 155
Piccinni, A., Del Debbio, A., Medda, P., Bianchi, C., Roncaglia, I., Veltri, A., Zanello, S., Massimetti, E., Origlia, N., & Domenici, L. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.002 · Cited by 120
Kleimann, A., Kotsiari, A., Sperling, W., Gröschl, M., Heberlein, A., Kahl, K. G., Hillemacher, T., Bleich, S., Kornhuber, J., & Frieling, H. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1336-6 · Cited by 70
“Nevertheless, studies in humans led to contradicting results concerning peripheral BDNF levels after ECT (Marano et al. 2007; Gedge et al. 2012).”
ResultBrunoni, A. R., Machado-Vieira, R., Zarate, C. A., Vieira, E. L. M., Vanderhasselt, M.-A., Nitsche, M. A., Valiengo, L., Benseñor, I. M., Lotufo, P. A., Gattaz, W. F., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.006 · Cited by 60
“(2006), in 16 treatment-resistant depressed patients and, later on, Marano et al. (2007) (n=15), Okamoto et al. (2008) (n=18), Piccinni et al. (2009) (n=18) and Haghighi et al. (2013) (n=20) showed an enhancement of BDNF levels; whereas Gedge et al. (2012) (n=11) and Fernandes et al. (2009) (n=15)…”
BackgroundFrancazio (2015) · doi:10.1016/j.psychres.2015.04.009 · Cited by 35
Metadata
- Authors
- Marano, C. M., Phatak, P., Vemulapalli, U. R., Sasan, A., Nalbandyan, M. R., Ramanujam, S., Soekadar, S., Demosthenous, M., & Regenold, W. T.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-04-15
- Volume
- 68
- Issue
- 04
- Pages
- 512-517
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2003052375
- Cited by
- 109
- References
- 0
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.